Annual report pursuant to Section 13 and 15(d)

Net Loss per Share of Common Stock (Details)

v3.22.2.2
Net Loss per Share of Common Stock (Details) - shares
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Net Loss per Share of Common Stock [Abstract]    
Convertible preferred equity,description 269 and 4,665 of the Company’s Class B Preferred Stock, which is convertible into 16,345,000 and 23,325,000 shares of common stock, is not included in the computation for the fiscal year ended June 30, 2022 and 2021, respectively. Such conversions would also create 16,345,000 and 23,325,000 cash warrants with an exercise price of approximately $.29. During the fiscal year ended June 30, 2022, 1,740 shares of Series B Stock had exercised conversions, so 8,700,000 related warrants were issued and outstanding as of June 30, 2022.  
Warrants exercisable shares 19,578,260 8,050,000